Clinical Trials
47 trialsMRI-PCOS
University Hospital, Lille
BIO-PSY
Institut du Cancer de Montpellier - Val d'Aurelle
Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity
SINA Health Education and Welfare Trust
Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33
Haihe Biopharma Co., Ltd.
EDI-PIO
University of Campinas, Brazil
CLVer
Jaeb Center for Health Research
A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer
Sandoz
NEOLETRIB
University Hospital, Akershus
MERIDIAN
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
AIRPORT-MPN
Ottawa Hospital Research Institute
Myoinositol Treatment and Asprosin Levels in PCOS
Near East University, Turkey
IGF Level in Breast Cancer Patients Treated With Metformin
Beni-Suef University
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
Calithera Biosciences, Inc
Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy
Samsung Medical Center
A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic
Medical University of Vienna
OLN-EME
Department of Medical Services Ministry of Public Health of Thailand
Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
Celgene
DENOCINA
Aalborg University Hospital
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
Bayer
Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance
Saudi German Hospital - Madinah
METEOR
Exelixis
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
DERMIA
Fundacion CRIS de Investigación para Vencer el Cáncer
Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol
Mansoura University
ZENITH
Azienda Ospedaliero, Universitaria Pisana
Decreasing Over Screening and Treatment of Cervical Precancers in Young Women
University of California, San Francisco
PregMet
Norwegian University of Science and Technology
Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors
Daiichi Sankyo
Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir
The Netherlands Cancer Institute
Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer
Sun Yat-sen University
Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
Milton S. Hershey Medical Center
pilPregMet
Norwegian University of Science and Technology
Neoadjuvant Endocrine Therapy in Breast Cancer
Guangdong Provincial People's Hospital
Pharmacogenetics of Metformin Action in PCOS
Virginia Commonwealth University
A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers
GlaxoSmithKline
Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects
Genentech, Inc.
Preoperative Pain Control in Liver Surgery Patients
Eastern Hepatobiliary Surgery Hospital
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
Bayer
Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers
Maxinase Life Sciences Ltd.
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
GlaxoSmithKline
A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia
GlaxoSmithKline
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
FDA Office of Orphan Products Development
Rapamycin Plus Bevacizumab in Advanced Cancers
University of Chicago
Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions
Nova Laboratories Limited
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
Point Therapeutics
Study of Talabostat in Advanced Melanoma
Point Therapeutics
Study of Talabostat and Cisplatin in Advanced Melanoma
Point Therapeutics